Craving Clinical Trial
Official title:
Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Cortex Training (CBOT) for Opioid Use Disorder
Opioid Use Disorders (OUD) cause significant burden to individuals, families, and the society. Our product - Computerized Chemosensory-Based Orbitofrontal Cortex Training (CBOT) - offers a cost-saving, home-based, user-friendly brain stimulation system that increased 6-month treatment retention of OUDs in a pilot study; and also, acutely reduced opioid withdrawal severity and negative affect during induction into opioid maintenance therapy. This study will establish its effectiveness in a broad category of OUD subjects at different stages of OUD care continuum.
Evon Medics proposes to evaluate the effectiveness of Computerized Chemosensory-Based Orbitofrontal Cortex Training (CBOT), as an alternative strategy for relapse prevention in patients with Opioid Use (OUD) and other substance use disorders (SUD). This treatment leverages the overlap in brain regions that process smell and mediate decision making. The CBOT is portable and can be used at home. This clinical trial is being conducted to demonstrate its utility for home application by nontreatment seeking and treatment-seeking OUD populations, to engage in long-term, successful opioid recovery. Key objectives of this project are to: (1) establish the effectiveness of CBOT for improved retention and relapse prevention in a large sample of OUD subjects; (2) establish its effectiveness for acute reduction of withdrawal severity and negative affect early in recovery; and (3) evaluate its safety, user-friendliness and acceptability. Accomplishment of these goals would lead to larger clinical trials for OUD and wider applications of CBOT in other addictive disorders. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT03576768 -
QuitFast: Evaluating Transcranial Magnetic Stimulation as a Tool to Reduce Smoking Directly Following a Quit Attempt
|
N/A | |
| Not yet recruiting |
NCT06026982 -
Gut Health and the Effect on Substance and Alcohol Cravings
|
Early Phase 1 | |
| Not yet recruiting |
NCT05535101 -
Non-invasive Brain Stimulation in Patients With Methamphetamine Use Disorder
|
N/A | |
| Completed |
NCT05074524 -
Repetitive Transcranial Magnetic Stimulation to Reduce Heroin Cravings
|
N/A | |
| Completed |
NCT03112824 -
Functional Assessment of Ashwagandaha Root Extract During Weight Loss
|
N/A | |
| Completed |
NCT03758027 -
CARESS: An Investigation of Effects of CARESS
|
N/A | |
| Not yet recruiting |
NCT03217929 -
Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) for Food Craving in Obese Individuals.
|
N/A | |
| Completed |
NCT01030289 -
The Effectiveness of Transcranial Direct Current Stimulation (tDCS) in Decreasing Food Cravings
|
N/A | |
| Withdrawn |
NCT04077385 -
Memory-Updating Technique to Reduce Food Craving and High Calorie Food Intake Among Individuals With Overweight/Obesity
|
N/A | |
| Completed |
NCT04310423 -
An Inflammatory Challenge Using Endotoxin
|
Phase 2 | |
| Recruiting |
NCT05076201 -
Process of Regulation in Addictions: Vulnerability Emotional Factors to Craving
|
N/A | |
| Not yet recruiting |
NCT06129461 -
A Single Session Self-guided Acceptance-based Digital Intervention Targeting Food Cravings in Pregnancy
|
N/A | |
| Recruiting |
NCT04338178 -
Efficacy of a Cognitive - Affective - Addictive Based Intervention to Decrease Food Craving in Obese Patients.
|
N/A | |
| Terminated |
NCT04162145 -
BRIDGE Device for Treatment of Opioid Withdrawal
|
N/A | |
| Completed |
NCT05430685 -
The Impact of Ashwagandha on Perceived Stress, Sleep and Food Cravings in College Students
|
Phase 2 | |
| Recruiting |
NCT04154111 -
Theta Burst Stimulation as a Tool to Decrease Drinking in Treatment-seeking Alcohol Users
|
N/A | |
| Recruiting |
NCT05277714 -
Neurofeedback Based on Near-infrared Spectroscopy as a Therapy for Food Addiction in Obese Subjects.
|
N/A | |
| Completed |
NCT04936594 -
TMS for Smoking Cessation in PLWHA Cessation in People Living With HIV/AIDS (PLWHA)
|
N/A | |
| Enrolling by invitation |
NCT05336188 -
Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder
|
Phase 2 | |
| Not yet recruiting |
NCT06247306 -
Using Neurofeedback to Understand the Relationship Between Stress and Alcohol Consumption
|
N/A |